Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View More Get Enquiry

Idelalisib

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Zydelig (EU/UK/India)

View More Get Enquiry

Vemurafenib

Strength:
240 mg

Form: Tablets

Reference Brands: Zelboraf (USA/EU), Vemura (India)

View More Get Enquiry

Abemaciclib

Strength:
50 mg, 100 mg, 150 mg, 200 mg

Form: Tablets

Reference Brands: Verzenio (USA/India)

View More Get Enquiry

Quizartinib Dihydrochloride

Strength:
17.7 mg , 26.5 mg

Form: Tablets

Reference Brands: Vanflyta (USA/EU)

View More Get Enquiry

Tucatinib

Strength:
50 mg, 150 mg

Form: Tablets

Reference Brands: Tukysa (USA, EU/UK), Tukavo (India)

View More Get Enquiry

Capivasertib

Strength:
160 mg

Form: Tablets

Reference Brands: Truqap (USA)

View More Get Enquiry

Toremifene Citrate

Strength:
60 mg

Form: Tablets

Reference Brands: Fareston(USA)

View More Get Enquiry

Ivosidenib

Strength:
250 mg

Form: Tablets

Reference Brands: Tibsovo (USA/EU)

View More Get Enquiry

Thioguanine

Strength:
20 mg, 25 mg, 40 mg

Form: Tablets

Reference Brands: Tabloid (USA), Lanvis (EU)

View More Get Enquiry

Tepotinib

Strength:
225 mg

Form: Tablets

Reference Brands: Tepmetko (USA/EU)

View More Get Enquiry

Tazemetostat

Strength:
20 mg

Form: Tablets

Reference Brands: Tazverik (USA/EU)

View More Get Enquiry

Capmatinib

Strength:
150 mg, 200 mg

Form: Tablets

Reference Brands: Tabrecta (USA/EU)

View More Get Enquiry

Regorafenib

Strength:
40 mg, 80 mg, 120 mg, 160 mg

Form: Tablets

Reference Brands: Stivarga (USA/EU)

View More Get Enquiry

Asciminib

Strength:
20 mg, 40 mg

Form: Tablets

Reference Brands: Scemblix (USA)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.